Back
Fortress Biotech Quote, Financials, Valuation and Earnings
Sponsored
FBIO
Sponsored
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
49
FBIO
Fortress Biotech
Last Price:
1.70
Seasonality Move:
20.97%
7 Day Trial
ALL ACCESS PASS
$
7
Trade on Tuesday. Profit on Friday. Rinse & Repeat
Get the full details now.Fortress Biotech Price Quote
$1.70
+0.09 (+5.59%)
(Updated: November 25, 2024 at 10:45 AM ET)
Fortress Biotech Key Stats
Sell
49
Fortress Biotech (FBIO)
is a Sell
Day range:
$1.55 - $1.62
52-week range:
$1.36 - $4.43
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.31
P/B ratio:
2.1%
Volume:
177.6K
Avg. volume:
552.4K
1-year change:
-26.82%
Market cap:
$44.4M
Revenue:
$84.5M
EPS:
$-13.27
How Much Does Fortress Biotech Make?
-
How Much Are Fortress Biotech's Sales Annually?
FBIO Revenues are $84.5M -
How Much Profit Does Fortress Biotech's Make A Year?
FBIO net income is -$60.6M
Is Fortress Biotech Growing As A Company?
-
What Is Fortress Biotech's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.58% -
What Is Fortress Biotech's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Fortress Biotech Stock Price Performance
-
Did Fortress Biotech Stock Go Up Last Month?
Fortress Biotech share price went down by -11.05% last month -
Did FBIO's Share Price Rise Over The Last Year?
FBIO share price fell by -26.82% over the past 1 year
What Is Fortress Biotech 52-Week High & Low?
-
What Is Fortress Biotech’s 52-Week High Share Price?
Fortress Biotech has traded as high as $4.43 over the past 52 weeks -
What Is Fortress Biotech’s 52-Week Low Share Price?
Fortress Biotech has traded as low as $1.36 over the past 52 weeks
Fortress Biotech Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Fortress Biotech?
-
How Much Debt Does Fortress Biotech Have?
Total long term debt quarterly is $53.7M -
How Much Cash Does Fortress Biotech Have?
Cash and short term investments quarterly total is $58.9M -
What Is Fortress Biotech’s Book Value Per Share?
Book value per share is 0.77
Is Fortress Biotech Cash Flow Positive?
-
What Is FBIO Cash Flow From Operations?
Cash flow from operations (TTM) is -$102.2M -
What Is Fortress Biotech’s Cash Flow From Financing?
Cash flow from financing (TTM) is $88.5M -
What Is Fortress Biotech’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$63K
Fortress Biotech Return On Invested Capital
-
Is Management Doing A Good Job?
FBIO return on invested capital is -94.06% -
What Is Fortress Biotech Return On Assets?
ROA measures how assets are converting to revenues and is -32.11% -
What Is FBIO Return On Equity?
ROE is a measure of profitability and is 0%
Fortress Biotech Earnings Date & Stock Price
-
What Is Fortress Biotech's Stock Price Today?
A single share of FBIO can be purchased today for 1.61 -
What Is Fortress Biotech’s Stock Symbol?
Fortress Biotech trades on the nasdaq under the ticker symbol: FBIO -
When Is Fortress Biotech’s Next Earnings Date?
The next quarterly earnings date for Fortress Biotech is scheduled on March 18, 2025 -
When Is FBIO's next ex-dividend date?
Fortress Biotech's next ex-dividend date is November 25, 2024 -
How To Buy Fortress Biotech Stock?
You can buy Fortress Biotech shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Fortress Biotech Competitors
-
Who Are Fortress Biotech's Competitors?
Below is a list of companies who compete with Fortress Biotech or are related in some way:
Fortress Biotech Dividend Yield
-
What Is FBIO Dividend Yield?
Fortress Biotech’s dividend yield currently is 0% -
What Is Fortress Biotech’s Payout Ratio?
Fortress Biotech’s payout ratio is -13.88% -
When Did Fortress Biotech Last Pay A Dividend?
The latest dividend pay date is November 25, 2024 -
What Is Fortress Biotech’s Dividend Per Share?
Fortress Biotech pays a dividend of $0.00 per share
Fortress Biotech Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | -181.48% |
Revenue: | -57.91% | -54.59% |
Analyst Recommendations
Buy Recommendations: | 1 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 14.33 |
Upside from Last Price: | 790.27% |